| (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | Phase II | rekrutiert |
| (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indole | Phase II / Phase III | rekrutiert |
| (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointe | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adul | Phase I | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on | Phase II | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy | Phase I / Phase II | rekrutiert |
| A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Phase I | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Prev | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treat | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in | Phase II | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinica | Phase II | rekrutiert |
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian C | Phase III | rekrutiert |
| A Study of Brenipatide in Adult Participants With Major Depressive Disorder | Phase III | rekrutiert |
| A Study of Brenipatide in Participants With Alcohol Use Disorder | Phase III | rekrutiert |
| A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 D | Phase III | rekrutiert |
| A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Cro | Phase III | rekrutiert |
| A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stro | Phase III | rekrutiert |
| A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovaria | Phase II / Phase III | rekrutiert |
| A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Phase III | rekrutiert |
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | Phase III | rekrutiert |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Particip | Phase II | rekrutiert |
| A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin | Phase III | rekrutiert |
| A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate | Phase I / Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart ( | Phase III | rekrutiert |
| A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradi | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sc | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Phase IV | rekrutiert |
| A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Ed | Phase II | rekrutiert |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People W | Phase III | rekrutiert |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma | Phase II / Phase III | rekrutiert |
| A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients | Phase II | rekrutiert |
| AI-POD Clinical Validation Study for Obese Patients | — | rekrutiert |
| AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT | — | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA | Phase II / Phase III | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Pat | Phase II | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | Phase II | rekrutiert |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination Wit | Phase I / Phase II | rekrutiert |
| Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With | Phase II | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | ohne Phasenangabe | rekrutiert |
| Brain Signal Training to Enhance Affect Down-regulation | Phase I / Phase II | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial | Phase II | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Gra | Phase III | rekrutiert |
| Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients Wit | ohne Phasenangabe | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Pl | Phase II | rekrutiert |
| DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrol | Phase III | rekrutiert |
| DEfeating PEnile CAncer-2 | ohne Phasenangabe | rekrutiert |
| Dabrafenib and/or Trametinib Rollover Study | Phase IV | rekrutiert |
| Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| EURO-STIM Registry | — | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do N | Phase II | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial | Phase II | rekrutiert |
| European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | Phase II | rekrutiert |
| Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patie | — | rekrutiert |
| FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early P | ohne Phasenangabe | rekrutiert |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FL | Phase II | rekrutiert |
| Functional Impact of Acute Respiratory Viral Infections in Older Adults | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation | ohne Phasenangabe | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy | ohne Phasenangabe | rekrutiert |
| Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Pati | Phase I | rekrutiert |
| Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease ( | Phase I | rekrutiert |
| Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untre | Phase III | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical | — | rekrutiert |
| Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multifo | ohne Phasenangabe | rekrutiert |
| Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elev | Phase III | rekrutiert |
| Lumbar Drainage of Intraventricular Hemorrhage | ohne Phasenangabe | rekrutiert |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | Phase III | rekrutiert |
| MacuTherm Performance Study in Patients With iAMD | ohne Phasenangabe | rekrutiert |
| Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Tri | ohne Phasenangabe | rekrutiert |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and | Phase III | rekrutiert |
| Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Ge | Phase III | rekrutiert |
| Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation ( | ohne Phasenangabe | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder | ohne Phasenangabe | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) | Phase IV | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Non Interventional German Leptomeningeal Disease Register | — | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Compl | Phase II | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastri | Phase II | rekrutiert |
| Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally A | Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid T | Phase I / Phase II | rekrutiert |
| Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mID | Phase II | rekrutiert |
| Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combinat | Phase III | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Adva | Phase III | rekrutiert |
| Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma | Phase II | rekrutiert |
| Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+) | — | rekrutiert |
| Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis | ohne Phasenangabe | rekrutiert |
| REtroperitoneal SArcoma Registry: an International Prospective Initiative | — | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy | Phase II | rekrutiert |
| Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neu | — | rekrutiert |
| Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners | ohne Phasenangabe | rekrutiert |
| Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in | ohne Phasenangabe | rekrutiert |
| Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Ther | Phase II / Phase III | rekrutiert |
| Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence | Phase III | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent | Phase II | rekrutiert |
| Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H R | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Croh | Phase II | rekrutiert |
| Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis | ohne Phasenangabe | rekrutiert |
| Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspira | — | rekrutiert |
| Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera | Phase III | rekrutiert |
| Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With P | Phase III | rekrutiert |
| Suprasorb® CNPendo Used for Negative Pressure Therapy in the Oesophagus and Rectum to Support De | — | rekrutiert |
| Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | Phase III | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells V | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therap | Phase IV | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |
| Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption | ohne Phasenangabe | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |
| Vorasidenib Maintenance for IDH Mutant Astrocytoma | Phase III | rekrutiert |
| WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC | Phase II | rekrutiert |